Total Product Lifecycle Considerations for Generative AIEnabled Devices

U.S. Food & Drug Administration

While interest in generative artificial intelligence (GenAI) tools across the health care sector has expanded rapidly, there remain open questions on the approach to regulating GenAI-enabled products that may fall within FDA’s jurisdiction, including, but not limited to, medical devices.